In DKD, recent evidence indicates that hyperglycemia and albuminuria stimulate increased exosome production from glomerular endothelial cells and tubular epithelial cells (109111)
Common side effects are generally mild and may include temporary injection site irritation, headache, or flushing
Canadian Journal of Zoology
Wegovy is a registered trademark of Novo Nordisk A/S Ozempic is a registered trademark of Novo Nordisk A/S Rybelsus is a registered trademark of Novo Nordisk A/S Zepbound is a registered trademark of Eli Lilly and Company Mounjaro is a registered trademark of Eli Lilly and Company Foundayo is a trademark of Eli Lilly and Company Amazon, Amazon One Medical, and Amazon Pharmacy are registered trademarks of Amazon.com, Inc
Gut-focused patients often feel a calming effect sooner, within the first 2 to 4 weeks
and next-generation triple agonists and combination regimens targeting more complex patient populations